In a filing, Conduit Pharmaceuticals Inc revealed its 10% Owner Nirland Ltd unloaded Company’s shares for reported $0.16 million on Oct 03 ’24. In the deal valued at $0.10 per share,1,500,000 shares were sold. As a result of this transaction, Nirland Ltd now holds 8,400,000 shares worth roughly $3.36 million.
Then, Nirland Ltd sold 1,368,991 shares, generating $140,458 in total proceeds. Upon selling the shares at $0.10, the 10% Owner now owns 7,031,009 shares.
Before that, Nirland Ltd sold 939,009 shares. Conduit Pharmaceuticals Inc shares valued at $96,530 were divested by the 10% Owner at a price of $0.10 per share. As a result of the transaction, Nirland Ltd now holds 6,092,000 shares, worth roughly $2.44 million.
Price Performance Review of CDT
On Friday, Conduit Pharmaceuticals Inc [NASDAQ:CDT] saw its stock unchanged to $0.40. Over the last five days, the stock has lost -25.47%. Conduit Pharmaceuticals Inc shares have fallen nearly -94.17% since the year began. Nevertheless, the stocks have fallen -99.88% over the past one year. While a 52-week high of $328.00 was reached on 01/10/25, a 52-week low of $0.37 was recorded on 05/07/25. SMA at 50 days reached $0.7880, while 200 days put it at $7.8435.
Levels Of Support And Resistance For CDT Stock
The 24-hour chart illustrates a support level at 0.3779, which if violated will result in even more drops to 0.3557. On the upside, there is a resistance level at 0.4243. A further resistance level may holdings at 0.4485. The Relative Strength Index (RSI) on the 14-day chart is 31.08, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.1073, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 86.10%. Stochastics %K at 14.52% indicates the stock is a buying.
